ISC-hpNSC (International Stem Cell Corporation)

N/A

Report date: 2026/01/21 20:00:47

Base Information

Drug NameISC-hpNSC (International Stem Cell Corporation)
Drug Alias NameHuman parthenogenetic neural stem cellshPSC NSCISC-hpNSChPNSChpNCSCs
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionDopaminergic cell replacementsNervous system modulators
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDuke UniversityInternational Stem Cell Corp
China Registration ClassN/A

Develop Information

Active CompaniesCyto Therapeutics Pty Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A